SEC Company Response from Chemomab Therapeutics Ltd. (CMMB) (CIK 0001534248) (CMMB) — Apr 26, 2021
Chemomab Therapeutics Ltd. (CMMB) (CIK 0001534248)
Date: April 26, 2021 · CIK: 0001534248 · Accession: 0001104659-21-054810
AI Filing Summary & Sentiment
File numbers found in text: 333-255249
Letter
Securities and Exchange Commission Division of Corporation Finance Attention: Division of Corporation Finance, Office of Life Sciences Chemomab Therapeutics Ltd. Registration Statement on Form S-3 File No. 333- 255249 VIA EDGAR
Re:
Dear Ms. Adams:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Chemomab Therapeutics Ltd. (the “Registrant”) hereby respectfully requests that the effectiveness of the Registration Statement on Form S-3 (File No. 333-255249) of the Registrant (the “Registration Statement”) be accelerated so that the Registration Statement will be declared effective at 5:00 p.m., Eastern Time, on April 28, 2021, or as soon thereafter as may be practicable.
It would be appreciated if, promptly after the Registration Statement has become effective, you would so confirm that event with our outside counsel, Mr. David S. Glatt of Meitar | Law Offices, by email at dglatt@meitar.com. The Company hereby authorizes Mr. Glatt to orally modify or withdraw this request for acceleration.
Sincerely,
/s/ Adi Mor
Show Raw Text
CORRESP
1
filename1.htm
April 26, 2021
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attention:
Division of Corporation Finance, Office of Life Sciences
Ms. Abby Adams
Re:
Chemomab Therapeutics Ltd.
Registration Statement on Form S-3
File No. 333- 255249
VIA EDGAR
Dear
Ms. Adams:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Chemomab Therapeutics Ltd. (the “Registrant”) hereby respectfully
requests that the effectiveness of the Registration Statement on Form S-3 (File No. 333-255249) of the Registrant (the “Registration
Statement”) be accelerated so that the Registration Statement will be declared effective at 5:00 p.m., Eastern Time, on April
28, 2021, or as soon thereafter as may be practicable.
It
would be appreciated if, promptly after the Registration Statement has become effective, you would so confirm that event with our outside
counsel, Mr. David S. Glatt of Meitar | Law Offices, by email at dglatt@meitar.com. The Company hereby authorizes Mr. Glatt
to orally modify or withdraw this request for acceleration.
Sincerely,
/s/ Adi Mor
Adi Mor
Chief Executive Officer
cc:
David S. Glatt, Adv., Meitar | Law Offices